We selected two genes for this validation experiment – Cyp24A1 from 20q13.2 region, amplification of which was significantly associated with lymph node metastasis and RAB27B from 18q22.2 region deletion of which was significantly associated with tumor grade in combined analyses. The gene discussed is CYP24A1; the disease is neoplasm.